Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDA: Angiwell-XR (Ranolazine) in Chronic Stable Angina
NCT03486561Phase 4Unknown
- Start
- Apr 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ranolazine in angina pectoris. Status: unknown.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT03486561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03486561.